Clinical Trial Update: Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial assessed the efficacy and safety of a fixed-dose combination of linagliptin and metformin in drug-naïve adults with type 2 diabetes. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Jentadueto (linagliptin/metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-04-24